BioSmart Co.Ltd Cash Flow Reinvestment Rate
BioSmart Co.Ltd cash flow reinvestment rate. BioSmart Co.Ltd (038460) has a Cash Flow Reinvestment Rate of 0.54x as of September 2025, reinvesting ₩4.12 Billion (capex ₩1.22 Billion plus investments ₩2.90 Billion) from operating cash flow of ₩7.59 Billion. Explore 038460 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of BioSmart Co.Ltd (2010–2024)
Cash flow reinvestment rate of BioSmart Co.Ltd from 2010 to 2024. Historical reinvestment intensity for BioSmart Co.Ltd across 9 annual periods. Explore 038460 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
BioSmart Co.Ltd Cash Flow Reinvestment Rate by Year (2010–2024)
BioSmart Co.Ltd cash flow reinvestment rate by year from 2010 to 2024. Year-by-year capital reinvestment analysis for BioSmart Co.Ltd. For the full cash flow conversion analysis, see BioSmart Co.Ltd (038460) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.60x | ₩17.49 Billion | ₩3.80 Billion | ₩8.66 Billion | ▼ -61.0% |
| 2023 | 11.80x | ₩13.75 Billion | ₩1.17 Billion | ₩4.92 Billion | ▲ +469.2% |
| 2022 | 2.07x | ₩11.58 Billion | ₩5.59 Billion | ₩5.87 Billion | ▼ -60.9% |
| 2021 | 5.30x | ₩6.37 Billion | ₩1.20 Billion | ₩5.22 Billion | ▲ +599.2% |
| 2018 | 0.76x | ₩4.41 Billion | ₩5.81 Billion | ₩3.34 Billion | ▼ -68.1% |
| 2014 | 2.37x | ₩3.10 Billion | ₩1.31 Billion | ₩927.27 Million | ▲ +1120.7% |
| 2013 | 0.19x | ₩748.17 Million | ₩3.85 Billion | ₩748.17 Million | ▲ +87.0% |
| 2012 | 0.10x | ₩895.45 Million | ₩8.62 Billion | ₩895.45 Million | ▼ -16.0% |
| 2010 | 0.12x | ₩589.05 Million | ₩4.76 Billion | ₩589.05 Million | — |